Pharmabotic Nordic A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About Pharmabotic Nordic A/S
Pharmabotic Nordic A/S (CVR number: 43526731) is a company from KØGE. The company recorded a gross profit of 43.1 kDKK in 2024. The operating profit was -4.5 kDKK, while net earnings were 83.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -4.4 %, which can be considered poor but Return on Equity (ROE) was 195.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 48.3 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Pharmabotic Nordic A/S's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2023 | 2024 | |
---|---|---|
Volume | ||
Net sales | ||
Gross profit | - 155.18 | 43.08 |
EBIT | - 979.11 | -4.50 |
Net earnings | - 979.52 | 83.50 |
Shareholders equity total | 0.87 | 84.37 |
Balance sheet total (assets) | 27.73 | 174.67 |
Net debt | -24.67 | -68.16 |
Profitability | ||
EBIT-% | ||
ROA | -3531.4 % | -4.4 % |
ROE | -112848.4 % | 195.9 % |
ROI | -112800.3 % | -10.6 % |
Economic value added (EVA) | - 979.11 | -3.30 |
Solvency | ||
Equity ratio | 3.1 % | 48.3 % |
Gearing | ||
Relative net indebtedness % | ||
Liquidity | ||
Quick ratio | 1.0 | 1.9 |
Current ratio | 1.0 | 1.9 |
Cash and cash equivalents | 24.67 | 68.16 |
Capital use efficiency | ||
Trade debtors turnover (days) | ||
Net working capital % | ||
Credit risk | ||
Credit rating | C | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.